292 related articles for article (PubMed ID: 24670217)
1. A robust graft-to strategy to form multifunctional and stealth zwitterionic polymer-coated mesoporous silica nanoparticles.
Zhu Y; Sundaram HS; Liu S; Zhang L; Xu X; Yu Q; Xu J; Jiang S
Biomacromolecules; 2014 May; 15(5):1845-51. PubMed ID: 24670217
[TBL] [Abstract][Full Text] [Related]
2. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
4. Lubrication and drug release behaviors of mesoporous silica nanoparticles grafted with sulfobetaine-based zwitterionic polymer.
Wan L; Tan X; Sun T; Sun Y; Luo J; Zhang H
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110886. PubMed ID: 32409044
[TBL] [Abstract][Full Text] [Related]
5. Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-l-alanine linkages.
Zhang L; Xue H; Gao C; Carr L; Wang J; Chu B; Jiang S
Biomaterials; 2010 Sep; 31(25):6582-8. PubMed ID: 20541254
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
7. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
8. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
Du X; Xiong L; Dai S; Qiao SZ
Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
[TBL] [Abstract][Full Text] [Related]
9. Surface functionalized mesoporous silica nanoparticles with natural proteins for reduced immunotoxicity.
Luo Z; Hu Y; Xin R; Zhang B; Li J; Ding X; Hou Y; Yang L; Cai K
J Biomed Mater Res A; 2014 Nov; 102(11):3781-94. PubMed ID: 24288246
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Polymer-Surface Decoration on Drug Delivery, Cellular Retention, and Action Mechanisms of Functionalized Mesoporous Silica Nanoparticles.
You Y; Hu H; He L; Chen T
Chem Asian J; 2015 Dec; 10(12):2744-54. PubMed ID: 26248202
[TBL] [Abstract][Full Text] [Related]
12. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
13. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
[TBL] [Abstract][Full Text] [Related]
16. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules.
Kim TW; Slowing II; Chung PW; Lin VS
ACS Nano; 2011 Jan; 5(1):360-6. PubMed ID: 21162552
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
18. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
[TBL] [Abstract][Full Text] [Related]
19. A Biodegradation Study of SBA-15 Microparticles in Simulated Body Fluid and in Vivo.
Choi Y; Lee JE; Lee JH; Jeong JH; Kim J
Langmuir; 2015 Jun; 31(23):6457-62. PubMed ID: 26013363
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery.
Zhang J; Yuan ZF; Wang Y; Chen WH; Luo GF; Cheng SX; Zhuo RX; Zhang XZ
J Am Chem Soc; 2013 Apr; 135(13):5068-73. PubMed ID: 23464924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
